Tryp Therapeutics Inc. announced the appointment of Australia-based Jason Carroll as the Company's new Chief Executive Officer, beginning October 1, 2023. Mr. Carroll brings a wealth of experience as a highly regarded life sciences executive, with an impressive 32-year career in the industry. In addition to his most recent role as Managing Director of iNova Pharmaceuticals Philippines, his extensive background includes leadership roles at industry giants Johnson & Johnson, Janssen Pharmaceutica, and Bristol-Myers Squibb.
Tryp Therapeutics Inc. Canadian Securities Exchange
Equities
TRYP
CA89854F1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | 0.00% | 0.00% | +50.00% |
1st Jan change | Capi. | |
---|---|---|
+34.40% | 50.85B | |
+0.46% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.96% | 26.11B | |
-21.63% | 19.13B | |
+8.36% | 13.05B | |
+27.13% | 12.16B | |
+24.48% | 12.08B |